Grantham, Mayo, Van Otterloo & Co (GMO)’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-33,500
Closed -$414K – 544
2018
Q3
$414K Sell
33,500
-109,662
-77% -$1.28M ﹤0.01% 454
2018
Q2
$1.48M Sell
143,162
-260,238
-65% -$3.03M 0.01% 333
2018
Q1
$4.38M Sell
403,400
-246,900
-38% -$3.01M 0.03% 244
2017
Q4
$7.25M Buy
650,300
+473,100
+267% +$5.03M 0.04% 193
2017
Q3
$1.82M Buy
+177,200
New +$1.68M 0.01% 332

Other funds holding CSTM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CSTM Position: Q4 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Constellium (CSTM) in Q4 2018, closing a stake of 33,500 shares — an estimated $414K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CSTM in Q3 2017 and held it in 5 quarters. The position peaked at $7.25M in Q4 2017. 137 funds tracked by Wall St. Rank hold CSTM as of Q4 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Constellium position as of Q4 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 33,500 Constellium shares in Q4 2018, an estimated $414K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Constellium in Q3 2017 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Constellium position peaked at $7.25M in Q4 2017.
  • 137 funds tracked by Wall St. Rank held Constellium as of Q4 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2018, filed 13 Feb 2019.